Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

Stocks We Like Even More Than BioMarin Pharmaceutical The Trump trade may have passed, but rates are still dropping and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

BioMarin Pharmaceutical Stock Down 0.6 % Shares of NASDAQ:BMRN opened at $71.53 on Wednesday. The firm has a 50 day simple moving average of $66.83 and a 200 day simple moving average of $67.78 ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Perspective Therapeutics (CATX – Research ...

BioMarin's has signed the first contract with an insurer in Germany for Roctavian, its recently approved gene therapy for haemophilia A, as it tests out its outcomes-based agreement (OBA ...

BioMarin Pharmaceutical Inc. has a one year low of $60.63 and a one year high of $94.85. The company has a 50-day simple moving average of $66.68 and a two-hundred day simple moving average of $67.87.

BioMarin (BMRN) announced positive new data from studies of Voxzogo in children with achondroplasia and in ongoing clinical trials ...

In this article, we are going to look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands against other biotech stocks. The biotechnology sector is gaining new momentum with better market ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...